“…In clinical trials with other types of transcutaneous implants, average functional gain compared to unaided hearing was 18.4 dB to 42.3 dB (Barbara, Perotti, Gioia, Volpini, & Monini, 2013;Bianchin, Bonali, Russo, & Tribi, 2015;Briggs et al, 2015;Busch, Giere, Lenarz, & Maier, 2015;Centric & Chennupati, 2014;Escorihuela-Garcia, Llopez-Carratala, Pitarch-Ribas, Latorre-Monteagudo, & Marco-Algarra, 2014;Hassepass et al, 2015;Hol, Nelissen, Agterberg, Cremers, & Snik, 2013;Ihler, Volbers, et al, 2014;Iseri et al, 2015;Lustig et al, 2001;Magliulo, Turchetta, Iannella, Valperga di Masino, & de Vincentiis, 2015;Manrique, Sanhueza, Manrique, & de Abajo, 2014;Monini et al, 2015;Rahne et al, 2015;Reinfeldt, Hakansson, Taghavi, Frede´n Jansson, et al, 2015;Riss et al, 2014;Siegert & Kanderske, 2013). So, 28.9 AE 4.2 dB achieved with the implant here fits well within the published range, while systems on an osseointegrated post tend to achieve higher values.…”